How much profit has Hologic made this year?
Hologic has made 966.42 M USD this year.
Hologic Net Income 2024
Hologic Net Income
966.42 M USD
Ticker
HOLX
ISIN
US4364401012
WKN
879100
In 2024, Hologic's profit amounted to 966.42 M USD, a 111.93% increase from the 456 M USD profit recorded in the previous year.
The Hologic Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2028e | 1.31 |
| 2027e | 1.27 |
| 2026e | 1.15 |
| 2025e | 1.05 |
| 2024e | 0.97 |
| 2023 | 0.46 |
| 2022 | 1.3 |
| 2021 | 1.87 |
| 2020 | 1.12 |
| 2019 | -0.2 |
| 2018 | -0.11 |
| 2017 | 0.76 |
| 2016 | 0.33 |
| 2015 | 0.13 |
| 2014 | 0.02 |
| 2013 | -1.17 |
| 2012 | -0.07 |
| 2011 | 0.16 |
| 2010 | -0.06 |
| 2009 | -2.22 |
| 2008 | -0.42 |
| 2007 | 0.09 |
| 2006 | 0.03 |
| 2005 | 0.03 |
| 2004 | 0.01 |
Hologic Revenue, EBIT, Net Income US4364401012 · 879100
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Hologic, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Hologic from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Hologic’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Hologic. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Hologic’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Hologic’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Hologic’s growth potential.
Hologic Revenue, EBIT and net profit per share
| Date | Hologic Revenue | Hologic EBIT | Hologic Net Income |
|---|---|---|---|
| 2028e | 5.15 B undefined | 1.67 B undefined | 1.31 B undefined |
| 2027e | 4.87 B undefined | 1.58 B undefined | 1.27 B undefined |
| 2026e | 4.58 B undefined | 1.43 B undefined | 1.15 B undefined |
| 2025e | 4.34 B undefined | 1.33 B undefined | 1.05 B undefined |
| 2024e | 4.1 B undefined | 1.22 B undefined | 966.42 M undefined |
| 2023 | 4.03 B undefined | 941 M undefined | 456 M undefined |
| 2022 | 4.86 B undefined | 1.65 B undefined | 1.3 B undefined |
| 2021 | 5.63 B undefined | 2.48 B undefined | 1.87 B undefined |
| 2020 | 3.78 B undefined | 1.15 B undefined | 1.12 B undefined |
| 2019 | 3.37 B undefined | 568.2 M undefined | -203.6 M undefined |
| 2018 | 3.22 B undefined | 508 M undefined | -111.3 M undefined |
| 2017 | 3.06 B undefined | 483.8 M undefined | 755.5 M undefined |
| 2016 | 2.83 B undefined | 559.1 M undefined | 330.8 M undefined |
| 2015 | 2.71 B undefined | 483.6 M undefined | 131.6 M undefined |
| 2014 | 2.53 B undefined | 363.6 M undefined | 17.3 M undefined |
| 2013 | 2.49 B undefined | 203.1 M undefined | -1.17 B undefined |
| 2012 | 2 B undefined | 163.1 M undefined | -73.6 M undefined |
| 2011 | 1.79 B undefined | 281.9 M undefined | 157.2 M undefined |
| 2010 | 1.68 B undefined | 181.7 M undefined | -62.8 M undefined |
| 2009 | 1.64 B undefined | 324.1 M undefined | -2.22 B undefined |
| 2008 | 1.67 B undefined | 377 M undefined | -415.6 M undefined |
| 2007 | 738.4 M undefined | 147.8 M undefined | 94.6 M undefined |
| 2006 | 462.7 M undefined | 65.1 M undefined | 27.4 M undefined |
| 2005 | 287.7 M undefined | 32.6 M undefined | 28.3 M undefined |
| 2004 | 228.7 M undefined | 12.6 M undefined | 12.2 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 228.7 M USD | 12.6 M USD | 12.2 M USD |
| 2005 | 287.7 M USD | 32.6 M USD | 28.3 M USD |
| 2006 | 462.7 M USD | 65.1 M USD | 27.4 M USD |
| 2007 | 738.4 M USD | 147.8 M USD | 94.6 M USD |
| 2008 | 1.67 B USD | 377 M USD | -415.6 M USD |
| 2009 | 1.64 B USD | 324.1 M USD | -2.22 B USD |
| 2010 | 1.68 B USD | 181.7 M USD | -62.8 M USD |
| 2011 | 1.79 B USD | 281.9 M USD | 157.2 M USD |
| 2012 | 2 B USD | 163.1 M USD | -73.6 M USD |
| 2013 | 2.49 B USD | 203.1 M USD | -1.17 B USD |
| 2014 | 2.53 B USD | 363.6 M USD | 17.3 M USD |
| 2015 | 2.71 B USD | 483.6 M USD | 131.6 M USD |
| 2016 | 2.83 B USD | 559.1 M USD | 330.8 M USD |
| 2017 | 3.06 B USD | 483.8 M USD | 755.5 M USD |
| 2018 | 3.22 B USD | 508 M USD | -111.3 M USD |
| 2019 | 3.37 B USD | 568.2 M USD | -203.6 M USD |
| 2020 | 3.78 B USD | 1.15 B USD | 1.12 B USD |
| 2021 | 5.63 B USD | 2.48 B USD | 1.87 B USD |
| 2022 | 4.86 B USD | 1.65 B USD | 1.3 B USD |
| 2023 | 4.03 B USD | 941 M USD | 456 M USD |
| 2024e | 4.1 B USD | 1.22 B USD | 966.42 M USD |
| 2025e | 4.34 B USD | 1.33 B USD | 1.05 B USD |
| 2026e | 4.58 B USD | 1.43 B USD | 1.15 B USD |
| 2027e | 4.87 B USD | 1.58 B USD | 1.27 B USD |
| 2028e | 5.15 B USD | 1.67 B USD | 1.31 B USD |
Hologic stock margins US4364401012 · 879100
The Hologic margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hologic. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hologic.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Hologic's sales revenue. A higher gross margin percentage indicates that the Hologic retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Hologic's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Hologic's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Hologic's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Hologic. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Hologic's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Hologic Margin History
| Hologic Gross margin | Hologic Profit margin | Hologic EBIT margin | Hologic Profit margin |
|---|---|---|---|
| 2028e | 55.85 % | 32.35 % | 25.36 % |
| 2027e | 55.85 % | 32.53 % | 26 % |
| 2026e | 55.85 % | 31.25 % | 25 % |
| 2025e | 55.85 % | 30.72 % | 24.23 % |
| 2024e | 55.85 % | 29.7 % | 23.57 % |
| 2023 | 55.85 % | 23.35 % | 11.31 % |
| 2022 | 62 % | 33.89 % | 26.77 % |
| 2021 | 67.39 % | 44.08 % | 33.23 % |
| 2020 | 59.67 % | 30.47 % | 29.53 % |
| 2019 | 51.96 % | 16.87 % | -6.05 % |
| 2018 | 52.73 % | 15.79 % | -3.46 % |
| 2017 | 52.99 % | 15.82 % | 24.7 % |
| 2016 | 55.19 % | 19.74 % | 11.68 % |
| 2015 | 52.96 % | 17.88 % | 4.87 % |
| 2014 | 50.27 % | 14.37 % | 0.68 % |
| 2013 | 46.67 % | 8.15 % | -47.06 % |
| 2012 | 49.66 % | 8.14 % | -3.68 % |
| 2011 | 51.6 % | 15.75 % | 8.79 % |
| 2010 | 43.86 % | 10.82 % | -3.74 % |
| 2009 | 52.38 % | 19.8 % | -135.4 % |
| 2008 | 53.3 % | 22.51 % | -24.82 % |
| 2007 | 46.76 % | 20.02 % | 12.81 % |
| 2006 | 41.78 % | 14.07 % | 5.92 % |
| 2005 | 38.89 % | 11.33 % | 9.84 % |
| 2004 | 36.86 % | 5.51 % | 5.33 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 36.86 % | 5.51 % | 5.33 % |
| 2005 | 38.89 % | 11.33 % | 9.84 % |
| 2006 | 41.78 % | 14.07 % | 5.92 % |
| 2007 | 46.76 % | 20.02 % | 12.81 % |
| 2008 | 53.3 % | 22.51 % | -24.82 % |
| 2009 | 52.38 % | 19.8 % | -135.4 % |
| 2010 | 43.86 % | 10.82 % | -3.74 % |
| 2011 | 51.6 % | 15.75 % | 8.79 % |
| 2012 | 49.66 % | 8.14 % | -3.68 % |
| 2013 | 46.67 % | 8.15 % | -47.06 % |
| 2014 | 50.27 % | 14.37 % | 0.68 % |
| 2015 | 52.96 % | 17.88 % | 4.87 % |
| 2016 | 55.19 % | 19.74 % | 11.68 % |
| 2017 | 52.99 % | 15.82 % | 24.7 % |
| 2018 | 52.73 % | 15.79 % | -3.46 % |
| 2019 | 51.96 % | 16.87 % | -6.05 % |
| 2020 | 59.67 % | 30.47 % | 29.53 % |
| 2021 | 67.39 % | 44.08 % | 33.23 % |
| 2022 | 62 % | 33.89 % | 26.77 % |
| 2023 | 55.85 % | 23.35 % | 11.31 % |
| 2024e | 55.85 % | 29.7 % | 23.57 % |
| 2025e | 55.85 % | 30.72 % | 24.23 % |
| 2026e | 55.85 % | 31.25 % | 25 % |
| 2027e | 55.85 % | 32.53 % | 26 % |
| 2028e | 55.85 % | 32.35 % | 25.36 % |
Hologic Aktienanalyse
What does Hologic do?
Hologic Inc. is a company from the United States that has established itself in the medical technology market. The company was founded in 1985 by Jay A. Stein, who set the goal of developing products and services that contribute to improving people's lives. Hologic specializes in artificial intelligence (AI) based diagnostic and therapeutic technology that increases the safety, effectiveness, and accuracy of medical procedures. The company initially focused on products in the field of mammography, but has since expanded to various sectors including imaging, gynecology, skeletal, and surgery. Hologic offers its customers products such as tomosynthesis systems, robot-assisted surgery systems, image analysis software, and a variety of reagents, kits, and tests. The company's business model is focused on innovative technology and science, aiming to optimize medical interventions and thus reduce and improve healthcare costs. Hologic is dedicated to research and development and has already filed dozens of patents. In the field of breast cancer diagnostics, Hologic has developed various mammography systems that have broken the standard of mammography. Through the use of tomosynthesis, a 3D-based diagnostic, it is possible to detect tumors and malignant changes earlier. This procedure has been widely used by many doctors around the world and has proven to be a reliable method for early detection of breast cancer. In gynecology, Hologic specializes in the development of diagnostic tests for infectious agents and hormones. The tests, such as the Aptima HPV test, are fast, sensitive, and reliable. They help to detect infectious agents earlier and initiate appropriate therapy. Hologic Taurus, a robot-assisted surgery system, has been developed to enable minimally invasive interventions that can be used to treat uterine fibroids. This method allows for a drastic reduction in hospital stay duration and recovery time. In the field of skeletal, Hologic offers various systems that are helpful in the diagnosis and treatment of osteoporosis. The widely used DXA system (Dual-Energy X-Ray Absorptiometer) is still one of the most accurate devices for measuring bone density. Additionally, Hologic is an company that not only focuses on medical technology but also pursues the larger goal of improving people's lives. An example of this is their partnership with the organization Pink Ribbon, which serves as a global ambassador for breast cancer early detection. Hologic has developed a special mammography system called Pink Affirm. For every system sold, Hologic donates a certain amount to Pink Ribbon. Overall, Hologic Inc. has become an important player in the field of medical technology and diagnostics. Through its innovative technologies and products, the company contributes to improving the health and lives of people worldwide. Hologic ist eines der beliebtesten Unternehmen auf Eulerpool.com.Hologic revenue by segment
In the annual report of the Hologic share (US4364401012, 879100, HOLX), it breaks down its revenues into 5 segments: 1. Diagnostics, 2. Breast Health, 3. GYN Surgical, 4. Skeletal Health, 5. Medical Aesthetics. The Hologic stock (WKN: 879100, ISIN: US4364401012, Ticker Symbol: HOLX) is a leading investment for investors interested in participating in the Health Care sector.
55 % Diagnostics
31 % Breast Health
10 % GYN Surgical
2 % Skeletal Health
2 % Medical Aesthetics
Net Income Details
Understanding Hologic's Profit Margins
The profit margins of Hologic represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Hologic's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Hologic's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Hologic's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Hologic’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Hologic stock
How has the profit developed compared to last year?
The profit has increased by 111.93% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Hologic publish its earnings?
Hologic publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Hologic?
The profits of Hologic are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Hologic?
You can learn more about the earnings of Hologic by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Hologic pay?
Over the past 12 months, Hologic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hologic is expected to pay a dividend of 0 USD.
What is the dividend yield of Hologic?
The current dividend yield of Hologic is .
When does Hologic pay dividends?
Hologic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Hologic?
Hologic paid dividends every year for the past 0 years.
What is the dividend of Hologic?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Hologic located?
Hologic is assigned to the 'Health' sector.
Wann musste ich die Aktien von Hologic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Hologic from 9/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/24/2024.
When did Hologic pay the last dividend?
The last dividend was paid out on 9/24/2024.
What was the dividend of Hologic in the year 2023?
In the year 2023, Hologic distributed 0 USD as dividends.
In which currency does Hologic pay out the dividend?
The dividends of Hologic are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Hologic stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Hologic
Our stock analysis for Hologic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hologic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
